Compared to control patients with benign prostatic hyperplasia (BPH), the patients with prostate cancer had higher levels of total PSA and free PSA, as well as a lower ratio of free PSA to total PSA (Table 1). This evidence concerns the gene KLK3 and prostate cancer.